Back
Product details:
CAS
1948-33-0
Purity
95%
TBHQ is a widely used Nrf2 activator, protects against Doxorubicin (DOX)-induced cardiotoxicity through activation of Nrf2. TBHQ is also an ERK activator; rescues Dehydrocorydaline (DHC)-induced cell proliferation inhibition in melanoma.
Properties
Name
TBHQ
Smiles
CC(C)(C)C=1C=C(O)C=CC1O
Targets
Please log in to see this information
2-(1,1-dimethylethyl)-1,4-benzenediol | 2-(tert-butyl)benzene-1,4-diol | 2-tert-butyl hydroquinone | 2-tert-butylhydroquinone | TBHQ | t-butylhydroquinone | tert-butylhydroquinone | tertiary butylhydroquinone | tertiary-butylhydroquinone | tert‑butyl hydroquinone
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
2-(1,1-dimethylethyl)-1,4-benzenediol | 2-(tert-butyl)benzene-1,4-diol | 2-tert-butyl hydroquinone | 2-tert-butylhydroquinone | TBHQ | t-butylhydroquinone | tert-butylhydroquinone | tertiary butylhydroquinone | tertiary-butylhydroquinone | tert‑butyl hydroquinone
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.